Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “administration”

271 pharma patents match "administration" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 271
Index total 30,257
Page 8 / 12

Quick answer

This filtered view shows 271 pharmaceutical patents matching "administration" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

271 results for “administration” · 30,257 patents in full index Clear search

  1. US 9012508

    Administration of intravenous ibuprofen

    Cumberland Pharmaceuticals Inc. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted
  2. US 9012467

    Compositions for intratumoral administration

    Covidien LP · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted
  3. US 9005604

    Aligned and electrospun piezoelectric polymer fiber assembly and scaffold

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted
  4. US 8952029

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Jazz Pharmaceuticals Ireland Limited · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  5. US 8920373

    Reduced volume formulation of glatiramer acetate and methods of administration

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted
  6. US 8906901

    Administration of dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted
  7. US 8883206

    Pharmaceutical composition and administrations thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted
  8. US 8809400

    Method to ameliorate oxidative stress and improve working memory via pterostilbene administration

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  9. US 8802628

    Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration

    IRONWOOD PHARMACEUTICALS, INC. · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  10. US 8802107

    VEGF antagonist formulations for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  11. US 8772306

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Jazz Pharmaceuticals, Inc. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  12. US 8728526

    Coacervate microparticles useful for the sustained release administration of therapeutic agents

    The United States of America, Represented by Secretary of Department of Health and Human Services, NIH · Granted May 20, 2014 · Expires May 15, 2034

    granted
  13. US 8653107

    Fentanyl composition for nasal administration

    Takeda Pharma A/S · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  14. US 8652443

    Foamable microemulsion compositions for topical administration

    Precision Dermatology, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  15. US 8586610

    Methods for the administration of iloperidone

    VANDA PHARMACEUTICALS INC. · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  16. US 8552034

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  17. US 8518390

    Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  18. US 8481046

    VEGF antagonist formulations for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted
  19. US 8465767

    Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles

    TAKEDA GMBH · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  20. US 8460713

    Administration of cells and cellular extracts for rejuvenation

    REGENICS AS · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted
  21. US 8445541

    Methods for concomitant administration of colchicine and a second active agent

    Takeda Pharmaceuticals U.S.A., Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  22. US 8440721

    Methods for concomitant administration of colchicine and a second active agent

    Takeda Pharmaceuticals U.S.A., Inc. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  23. US 8440722

    Methods for concomitant administration of colchicine and a second active agent

    Takeda Pharmaceuticals U.S.A., Inc. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  24. US 8420619

    Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein

    Ceregene, Inc. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted